Post by
fundtrader on Sep 16, 2016 3:13am
Teva paid 40 billion for allergans generic business
lots of money in generics..i guess cxr is worth close to 10 billion then or 80$ us a share
Comment by
LaticelnExile on Oct 13, 2016 10:36pm
This post has been removed in accordance with Community Policy
Comment by
Craigbad on Oct 13, 2016 10:40pm
In fairness he didn't say $80 per share, he said $80US per share! Lol I just hope he didn't scare any hard working, innocent shorts into covering.